REVERE PHARMACEUTICALS
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

REVERE PHARMACEUTICALS Trademark

Serial Number: 97861966

REVERE PHARMACEUTICALS is a trademark filed by Revere Pharmaceuticals, Inc. on March 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Revere Pharmaceuticals, Inc. (3 trademarks)

36 Orvis Road
Arlington, MA 02474

Entity Type: 03

Trademark Details

Filing Date

March 28, 2023

Registration Date

Not Registered

Published for Opposition

January 14, 2025

Goods & Services

Pharmaceutical preparations for the treatment oncological diseases and conditions, kidney diseases and conditions, inflammatory diseases and conditions and central nervous system diseases and conditions

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 13, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 13, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2024 CNSA
CORRESPONDENCE E-MAILED
Mar 13, 2024 GRML
SUSPENSION LETTER WRITTEN
Mar 13, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 21, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2023 NWOS
NEW APPLICATION ENTERED
Mar 31, 2023 NWAP